AGH Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$723K Buy
1,071
+75
+8% +$44.6K 0.42% 52
2026
Q2
$499K Sell
996
-1
-0.1% -$480 0.32% 64
2026
Q1
$490K Sell
997
-35
-3% -$19K 0.36% 59
2025
Q4
$598K Sell
1,032
-6
-0.6% -$3.39K 0.45% 44
2025
Q3
$503K Buy
1,038
+186
+22% +$86.6K 0.37% 58
2025
Q2
$345K Sell
852
-134
-14% -$56K 0.28% 73
2025
Q1
$491K Sell
986
-132
-12% -$71.5K 0.47% 45
2024
Q4
$582K Buy
+1,118
New +$615K 0.54% 40

Other funds holding TMO

AGH Wealth Advisors's TMO Position: Q3 2026 in Review

AGH Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.5% in Q3 2026, buying an estimated $44.6K and bringing the position to 1,071 shares worth $723K. The position accounts for 0.42% of the portfolio, ranked #52.

AGH Wealth Advisors first reported a position in TMO in Q4 2024 and has held it in 8 quarters since. 2,793 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • AGH Wealth Advisors held 1,071 shares of Thermo Fisher Scientific worth $723K as of Q3 2026.
  • AGH Wealth Advisors bought 75 Thermo Fisher Scientific shares in Q3 2026, an estimated $44.6K.
  • Thermo Fisher Scientific made up 0.42% of AGH Wealth Advisors's portfolio in Q3 2026, its #52 holding.
  • AGH Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 8 quarters since.
  • 2,793 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on AGH Wealth Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.